GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Global Pharmatech Inc (OTCPK:GBLP) » Definitions » 5-Year EBITDA Growth Rate

Global Pharmatech (Global Pharmatech) 5-Year EBITDA Growth Rate : 0.00% (As of Jun. 2008)


View and export this data going back to . Start your Free Trial

What is Global Pharmatech 5-Year EBITDA Growth Rate?

Global Pharmatech's EBITDA per Share for the three months ended in Jun. 2008 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Global Pharmatech's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Global Pharmatech's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Pharmatech's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Global Pharmatech's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Global Pharmatech's 5-Year EBITDA Growth Rate falls into.



Global Pharmatech 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Global Pharmatech  (OTCPK:GBLP) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Global Pharmatech 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Global Pharmatech's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Pharmatech (Global Pharmatech) Business Description

Traded in Other Exchanges
N/A
Address
No. 75, Fa Yuen Street, Mong Kok, Flat/RM 705, 7/F, Fa Yuen Commercial Building, Hong Kong, HKG
Global Pharmatech Inc through its subsdiaries, discovers, develops, manufactures and markets proprietary drugs developed based on Traditional Chinese Medicine (TCM) while utilizing modern facilities and advanced R&D technologies. Geographically, the major business activities are carried out through People's Republic of China with sales distribution in China, Hong Kong, Singapore, Malaysia, Indonesia and USA.

Global Pharmatech (Global Pharmatech) Headlines

No Headlines